Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies”

研究成果: 雜誌貢獻 › 快報 › 同行評審

原文	英語
頁（從 - 到）	369-370
頁數	2
期刊	Otolaryngology - Head and Neck Surgery (United States)
卷	160
發行號	2
DOIs	https://doi.org/10.1177/0194599818813522
出版狀態	已發佈 - 2月 1 2019

ASJC Scopus subject areas

@article{2dfad6cd2ebc48d5a30b3a3e8d1484a8,

title = "Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies”",

author = "Hsu, {Yuan Pin} and Hsu, {Chin Wang} and Chiehfeng Chen",

year = "2019",

month = feb,

day = "1",

doi = "10.1177/0194599818813522",

language = "English",

volume = "160",

pages = "369--370",

journal = "Otolaryngology - Head and Neck Surgery (United States)",

issn = "0194-5998",

publisher = "Mosby Inc.",

number = "2",

}

TY - JOUR

T1 - Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia

T2 - Considerations from Observational Studies”

AU - Hsu, Yuan Pin

AU - Hsu, Chin Wang

AU - Chen, Chiehfeng

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85061305764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061305764&partnerID=8YFLogxK

U2 - 10.1177/0194599818813522

DO - 10.1177/0194599818813522

M3 - Letter

C2 - 30798740

AN - SCOPUS:85061305764

SN - 0194-5998

VL - 160

SP - 369

EP - 370

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

IS - 2

ER -